-
biology, enzymology, crystallographic fragment screening, and structure-guided drug discovery to define novel mechanisms of RT inhibition and develop new approaches for targeting protein–nucleic acid
-
) the regulation and function of tumor suppressor p53 and its gain-of-function mutants in cancer; 2) the role of tumor suppressors, including p53 and its target genes, in tumor microenvironment and tumor immunology
-
Associate will work on a project in a laboratory dedicated to studying the molecular pathogenesis of Parkinson’s Disease and related disorders, identifying therapeutic targets and testing new therapeutic
-
fundamental questions. Active areas of research include T cell receptor discovery, membrane-tethered cytokine technologies, tumor resistance mutations, target antigen discovery, and preclinical development